Abstract 5327: In vivo fluorescence imaging of solid tumor-bisphosphonate interaction
Rao V. Papineni(University of Kansas Medical Center), Alan Pollack(Sylvester Comprehensive Cancer Center), John Pizzonia(Carestream (United States)), Mansoor Ahmed(University of Miami), Thirupandiyur S. Udayakumar(Fox Chase Cancer Center)
Cited by 3
Related Papers
Membrane type-1-matrix metalloproteinase expressed by prostate carcinoma cells cleaves human laminin-5 beta3 chain and induces cell migration.
|PubMed|2003|131
MDM2 and Ki-67 Predict for Distant Metastasis and Mortality in Men Treated With Radiotherapy and Androgen Deprivation for Prostate Cancer: RTOG 92-02
|Journal of Clinical Oncology|2009|102
ON MODERN TECHNICAL APPROACHES OF THREE-DIMENSIONAL HIGH-DOSE LATTICE RADIOTHERAPY (LRT)
|Cureus|2010|97
The E2F1/Rb and p53/MDM2 Pathways in DNA Repair and Apoptosis: Understanding the Crosstalk to Develop Novel Strategies for Prostate Cancer Radiotherapy
|Seminars in Radiation Oncology|2010|60